Outcomes | Illustrative comparative risksa (95% CI) | Relative effect (95% CI) | No of Participants (studies) | Quality of the evidence (GRADE) | Comments | |
---|---|---|---|---|---|---|
Assumed risk Control | Corresponding risk Tranexamic acid versus placebo | |||||
Cerebrovascular accident | Study population | RR 0.93 (0.62 to 1.39) | 6775 (22 studies) | ⊕ ⊕ ⊕⊝ moderateb | ||
13 per 1000 | 12 per 1000 (8 to 18) | |||||
Moderate | ||||||
0 per 1000 | 0 per 1000 (0 to 0) | |||||
Seizure | Study population | RR 6.67 (1.77 to 25.20) | 4911 (4 studies) | ⊕ ⊕ ⊕ ⊕ highc,d | ||
1 per 1000 | 5 per 1000 (1 to 20) | |||||
Moderate | ||||||
0 per 1000 | 0 per 1000 (0 to 0) | |||||
Reoperation for bleeding | Study population | RR 0.46 (0.31 to 0.68) | 6259 (16 studies) | ⊕ ⊕ ⊕ ⊕ highe,f | ||
25 per 1000 | 11 per 1000 (8 to 17) | |||||
Moderate | ||||||
22 per 1000 | 10 per 1000 (7 to 15) | |||||
Mortality | Study population | RR 0.82 (0.53 to 1.28) | 6414 (17 studies) | ⊕ ⊕ ⊕⊝ moderateb,g | ||
13 per 1000 | 10 per 1000 (7 to 16) | |||||
Moderate | ||||||
0 per 1000 | 0 per 1000 (0 to 0) | |||||
Myocardial infarction | Study population | RR 0.9 (0.78 to 1.05) | 6714 (23 studies) | ⊕ ⊕ ⊕⊝ moderatee | ||
97 per 1000 | 87 per 1000 (75 to 101) | |||||
Moderate | ||||||
0 per 1000 | 0 per 1000 (0 to 0) | |||||
Acute renal insufficiency | Study population | RR 1.01 (0.78 to 1.3) | 5954 (14 studies) | ⊕ ⊕ ⊕⊝ moderateb | ||
37 per 1000 | 37 per 1000 (29 to 48) | |||||
Moderate | ||||||
20 per 1000 | 20 per 1000 (16 to 26) | |||||
Transfusion of any blood products | Study population | RR 0.64 (0.52 to 0.78) | 5360 (11 studies) | ⊕⊝⊝⊝ very lowb,h | ||
553 per 1000 | 354 per 1000 (288 to 432) | |||||
Moderate | ||||||
560 per 1000 | 358 per 1000 (291 to 437) | |||||
Postoperative chest tube drainage in the first 24 h | The mean postoperative chest tube drainage in the first 24 h in the intervention groups was 206.19 lower (248.23 to 164.15 lower) | 6247 (16 studies) | ⊕⊝⊝⊝ very lowh,i |